HLA-DPβ chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy

International Journal of Immunogenetics

Volumn 35, Issue 1, 2008, Pages 37-43

  Shichi, D ^a   Matsumori, A ^b   Naruse, T K ^a   Inoko, H ^c   Kimura, A ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DPB1 ANTIGEN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; GENE DOSAGE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C VIRUS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIRUS PATHOGENESIS; ASIAN; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; HEPATITIS C; IMMUNOLOGY;

HEPATITIS C VIRUS;

ANTIGENS, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C; HLA-DP ANTIGENS; HUMANS; POLYMORPHISM, GENETIC;

EID: 37849004519     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00733.x     Document Type: Article

References (51)

1. Berretta, F., Butler, R.H., Diaz, G., Sanarico, N., Arroyo, J., Fraziano, M. et al 2003) Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens, 62, 459.
2. Busson, M., Castelli, F.A., Wang, X.F., Cohen, W.M., Charron, D., Menez, A. et al 2006) Prediction of CD4 (+) T cell epitopes restricted to HLA-DP4 molecules. Journal of Immunological Methods, 317, 144.
3. Castelli, F.A., Buhot, C., Sanson, A., Zarour, H., Pouvelle-Moratille, S., Nonn, C. et al 2002) HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. Journal of Immunology, 169, 6928.
4. Diaz, G., Amicosante, M., Jaraquemada, D., Butler, R.H., Guillen, M.V., Sanchez, M. et al 2003) Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84 in T cell allorecognition and peptide binding. International Immunology, 15, 565.
5. Dong, R.P., Kamikawaji, N., Toida, N., Fujita, Y., Kimura, A. Sasazuki, T. (1995) Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein. Journal of Immunology, 154, 4536.
6. El-Ani, D. Zimlichman, R. (2003) TNFalpha stimulated ATP-sensitive potassium channels and attenuated deoxyglucose and Ca uptake of H9c2 cardiomyocytes. Annals of the New York Academy of Sciences, 1010, 716.
7. Fontenot, A.P., Torres, M., Marshall, W.H., Newman, L.S. Kotzin, B.L. (2000) Beryllium presentation to CD4 (+) T cells underlies disease- susceptibility HLA-DP alleles in chronic beryllium disease. Proceedings of the National Academy of Sciences of the USA 97, 12717.
8. de Graaff, P.M., Heidema, J., Poelen, M.C., van Dijk, M.E., Lukens, M.V., van Gestel, S.P. et al 2004) HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. Virology, 326, 220.
9. Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O. et al 2002) Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 34, 233.
10. Hori, T., Kamikawaji, N., Kimura, A., Sone, T., Komiyama, N., Komiyama, S. et al 1996) Japanese cedar pollinosis and HLA-DP5. Tissue Antigens, 47, 485.
11. Horton, R., Wilming, L., Rand, V., Lovering, R.C., Bruford, E.A., Khodiyar, V.K. et al 2004) Gene map of the extended human MHC. Nature Reviews Genetics, 5, 889.
12. Ihaka, R. Gentleman, R. (1996) R: a language for data analysis and graphics. Journal of Computational and Graphical Statistics, 5, 299.
13. Inoko, H. Ota, M. (1993) PCR-RFLP. In: Handbook of HLA Typing Techniques (ed. by J. Bidwell K. M. Hui pp. 9. CRC Press, Boca Raton, Florida.
14. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L. et al 1996) Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proceedings of the National Academy of Sciences of the USA. 93, 734.
15. + current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts. Circulation Journal, 70, 605.
16. Kuwata, S., Yanagisawa, M., Nakagawa, H., Saeki, H., Etoh, T., Miyamoto, M. et al 1996) HLA-DM gene polymorphism in atopic dermatitis. Journal of Allergy and Clinical Immunology, 98, S192.
17. Kuzushita, N., Hayashi, N., Katayama, K., Hiramatsu, N., Yasumaru, M., Murata, H. et al 1996) Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. Journal of Medical Virology, 48, 1.
18. Kuzushita, N., Hayashi, N., Moribe, T., Katayama, K., Kanto, T., Nakatani, S. et al 1998) Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology, 27, 240.
19. Lancaster, A., Nelson, M.P., Meyer, D., Thomson, G. Single, R.M. (2003) PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pacific Symposium on Biocomputing, 8, 514.
20. Marsh, S.G., Albert, E.D., Bodmer, W.F., Bontrop, R.E., Dupont, B., Erlich, H.A. et al 2002) Nomenclature for factors of the HLA system, 2002. Human Immunology, 63, 1213.
21. Matsumori, A. (2005) Hepatitis C virus infection and cardiomyopathies. Circulation Research, 96, 144.
22. Matsumori, A., Furukawa, Y., Hasegawa, K., Sato, Y., Nakagawa, H., Morikawa, Y. et al 2002) Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys. Circulation Journal, 66, 323.
23. Matsumori, A., Matoba, Y., Nishio, R., Shioi, T., Ono, K. Sasayama, S. (1996) Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 222, 678.
24. Matsumori, A., Matoba, Y. Sasayama, S. (1995) Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation, 92, 2519.
25. Matsumori, A., Ohashi, N., Hasegawa, K., Sasayama, S., Eto, T., Imaizumi, T. et al 1998) Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Japanese Circulation Journal, 62, 389.
26. Matsumori, A., Ohashi, N., Nishio, R., Kakio, T., Hara, M., Furukawa, Y. et al 1999) Apical hypertrophic cardiomyopathy and hepatitis C virus infection. Japanese Circulation Journal, 63, 433.
27. Matsumori, A., Shimada, T., Chapman, N.M., Tracy, S.M. Mason, J.W. (2006) Myocarditis and heart failure associated with hepatitic C virus infection. Journal of Cardiac Failure, 12, 293.
28. Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y. Sasayama, S. (1994) Increased circulating cytokines in patients with myocarditis and cardiomyopathy. British Heart Journal, 72, 561.
29. Mayo, M.J. (2003) Extrahepatic manifestations of hepatitis C infection. American Journal of the Medical Sciences, 325, 135.
30. McCluskey, J. Peh, C.A. (1999) The human leukocyte antigens and clinical medicine: and overview. Reviews in Immunogenetics, 1, 3.
31. Naruse, T.K., Kawata, H., Ishihara, M., Ando, A., Kagiya, M., Nose, Y. et al 1996) Analysis on allelic variation of the HLA-DMB gene in Japanese by PCR-RFLP as well as direct DNA sequencing and identification of a new DMB allele. DMB*0105. Tissue Antigens, 47, 530.
32. Naruse, T.K., Nose, Y., Kagiya, M., Liao, G., Nabeya, N., Kimura, M. et al 1995) Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65 of the DPB1 molecule. Human Immunology, 42, 123.
33. Omura, T., Yoshiyama, M., Hayashi, T., Nishiguchi, S., Kaito, M., Horiike, S. et al 2005) Core protein of hepatitis C virus induces cardiomyopathy. Circulation Research, 96, 148.
34. Rammensee, H.G., Friede, T. Stevanoviic, S. (1995) MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178.
35. Richard, P., Villard, E., Charron, P. Isnard, R. (2006) The genetic bases of cardiomyopathies. Journal of the American College of Cardiology, 48, A79.
36. Rudolph, M.G., Stanfield, R.L. Wilson, I.A. (2006) How TCRs bind MHCs, peptides, and coreceptors. Annual Review of Immunology, 24, 419.
37. Saito, S., Ota, S., Yamada, E., Inoko, H. Ota, M. (2000) Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens, 56, 522.
38. Sakaguchi, M., Nakayama, T., Kaku, H., Taniguchi, K., Saito, S., Kimura, A. et al 2002) Analysis of HLA in children with gelatin allergy. Tissue Antigens, 59, 412.
39. Seidman, J.G. Seidman, C. (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 104, 557.
40. Seki, T., Ota, M., Furuta, S., Fukushima, H., Kondo, T., Hino, K. et al 1992) HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology, 103, 1041.
41. Shichi, D., Kikkawa, E.F., Ota, M., Katsuyama, Y., Kimura, A., Matsumori, A. et al 2005) The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy. Tissue Antigens, 66, 200.
42. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L. et al 1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature, 368, 215.
43. Strader, D.B., Wright, T., Thomas, D.L. Seeff, L.B. (2004) American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, 1147.
44. Svejgaard, A. Ryder, L.P. (1994) HLA and disease associations: detecting the strongest association. Tissue Antigens, 43, 18.
45. Takahashi, M., Yasunami, M., Kubota, S., Tamai, H. Kimura, A. (2006) HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves' disease in the Japanese. Human Immunology, 67, 47.
46. Takeda, A., Sakata, A. Takeda, N. (1999) Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy. Molecular and Cellular Biochemistry, 195, 257.
47. Taylor, G.M., Dearden, S., Ravetto, P., Ayres, M., Watson, P., Hussain, A. et al 2002) United Kingdom Childhood Cancer Study. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Human Molecular Genetics, 11, 1585.
48. Teragaki, M., Nishiguchi, S., Takeuchi, K., Yoshiyama, M., Akioka, K. Yoshikawa, J. (2003) Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy. Heart and Vessels, 18, 167.
49. Yokoyama, T., Nakano, M., Bednarczyk, J.L., McIntyre, B.W., Entman, M. Mann, D.L. (1997) Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation, 95, 1247.
50. Zangenberg, G., Huang, M.M., Arnheim, N. Erlich, H. (1995) New HLA-DPB1 alleles generated by interallelic gene conversion detected by analysis of sperm. Nature Genetics, 10, 407.
51. Zen, K., Irie, H., Doue, T., Takamiya, M., Yamano, T., Sawada, T. et al 2005) Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy. International Heart Journal, 46, 231.